Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 4, 2011, Pages

  Widder, Joachim ^a   Postmus, Douwe ^a   Ubbels, Jan F ^a   Wiegman, Erwin M ^a   Langendijk, Johannes A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

3D conformal radiotherapy; Health related quality of life; High precision conformal radiotherapy; Non small cell lung cancer; Stereotactic body radiotherapy

Indexed keywords

3D-CONFORMAL RADIOTHERAPY; HEALTH-RELATED QUALITY OF LIVES; HIGH-PRECISION; NON SMALL CELL LUNG CANCER; STEREOTACTIC BODY RADIOTHERAPY;

BIOLOGICAL ORGANS; DISEASES; HEALTH RISKS; HIGH ENERGY PHYSICS; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; RATING; RISK ANALYSIS; RISK ASSESSMENT;

THREE DIMENSIONAL;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DYSPNEA; EARLY CANCER; FEMALE; HUMAN; INOPERABLE CANCER; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; STEREOTACTIC TREATMENT; THREE DIMENSIONAL IMAGING;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CONFIDENCE INTERVALS; DIAGNOSTIC SELF EVALUATION; DOSE FRACTIONATION; DYSPNEA; FEMALE; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RADIOSURGERY; RADIOTHERAPY, CONFORMAL; REGRESSION ANALYSIS;

EID: 80255123376     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.03.052     Document Type: Article

References (27)

1. S. Lo, A. Fakiris, E. Chang, N. Mayr, J. Wang, and L. Papiez Stereotactic body radiation therapy: A novel treatment modality Nat Rev Clin Oncol 7 2010 44 54
2. S. Senan, and F. Lagerwaard Stereotactic radiotherapy for stage I lung cancer: Current results and new developments Cancer/Radiotherapie 14 2010 115 118
3. R.D. Timmerman, B.D. Kavanagh, L.C. Cho, L. Papiez, and L. Xing Stereotactic body radiation therapy in multiple organ sites J Clin Oncol 25 2007 947 952 (Pubitemid 350002860)
4. R. Timmerman, R. Paulus, J. Galvin, J. Michalski, W. Straube, and J. Bradley Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
5. I. Grills, V. Mangona, R. Welsh, G. Chmielewski, E. McInerney, and S. Martin Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
6. N. Van Der Voort Van Zyp, J. Prevost, B. Van Der Holt, C. Braat, R. Van Klaveren, and P. Pattynama Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 77 2010 31 37
7. P.M. Kenny, M.T. King, R.C. Viney, M.J. Boyer, C.A. Pollicino, and J.M. McLean Quality of life and survival in the 2 years after surgery for non-small-cell lung cancer J Clin Oncol 26 2008 233 241
8. J. Langendijk, N. Aaronson, J. de Jong, G. ten Velde, M. Muller, and B. Slotman Quality of life after curative radiotherapy in stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 53 2002 847 853 (Pubitemid 34722628)
9. G. Colice, S. Shafazand, J. Griffin, R. Keenan, and C. Bolliger Physiologic evaluation of the patient with lung cancer being considered for resectional surgery Chest 132 3 Suppl 2007 161S 177S
10. N. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull, and N. Duez The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376 (Pubitemid 23073154)
11. B. Bergman, N.K. Aaronson, S. Ahmedzai, S. Kaasa, and M. Sullivan The EORTC QLQ-LC13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life Eur J Cancer 30A 1994 635 642 (Pubitemid 24164250)
12. J.A. Langendijk, N.K. Aaronson, J.M.A. de Jong, G.P.M. ten Velde, M.J. Muller, and R.J. Lamers Prospective study on quality of life before and after radical radiotherapy in non-small-cell lung cancer J Clin Oncol 19 2001 2123 2133 (Pubitemid 32366967)
13. B. Movsas, J. Moughan, L. Sarna, C. Langer, M. Werner-Wasik, and N. Nicolaou Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801 J Clin Oncol 27 2009 5816 5822
14. D. Osoba, G. Rodrigues, J. Myles, B. Zee, and J. Pater Interpreting the significance of changes in health-related quality-of- life scores J Clin Oncol 16 1998 139 144 (Pubitemid 28041591)
15. J. Widder, M. Hollander, J. Ubbels, R. Bolt, and J. Langendijk Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation Radioth Oncol 94 2010 42 46
16. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
17. P.F. Jason, and R. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
18. K. Cocks, M.T. King, G. Velikova, P.M. Fayers, and J.M. Brown Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials Eur J Cancer 44 2008 1793 1798
19. H. Onishi, H. Shirato, Y. Nagata, M. Hiraoka, M. Fujino, and K. Gomi Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 S100
20. F.J. Lagerwaard, C.J.A. Haasbeek, E.F. Smit, B.J. Slotman, and S. Senan Outcomes of risk-adapted fractionated stereotactic radiotherapy for Stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 70 2008 685 692
21. P. Baumann, J. Nyman, M. Hoyer, B. Wennberg, G. Gagliardi, and I. Lax Outcome in a prospective Phase II trial of medically inoperable Stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
22. F. Lagerwaard, S. Senan, J. Van Meerbeeck, and W. Graveland Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer? Radiother Oncol 63 2002 151 157 (Pubitemid 34628403)
23. N. Nguyen, L. Garland, J. Welsh, R. Hamilton, D. Cohen, and V. Vinh-Hung Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma Cancer Treatment Rev 34 2008 719 727
24. A. Chi, Z. Liao, N. Nguyen, J. Xu, B. Stea, and R. Komaki Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications Radiother Oncol 94 2010 1 11
25. L. Potters, B. Kavanagh, J. Galvin, J. Hevezi, N. Janjan, and D. Larson American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guideline for the Performance of Stereotactic Body Radiation Therapy Int J Radiat Oncol Biol Phys 76 2010 326 332
26. S. Swensen, M. Silverstein, D. Ilstrup, C. Schleck, and E. Edell The probability of malignancy in solitary pulmonary nodules: Application to small radiologically indeterminate nodules Arch Intern Med 157 1997 849 855 (Pubitemid 28337035)
27. G. Herder, H. Van Tinteren, R. Golding, P. Kostense, E. Comans, and E. Smit Clinical prediction model to characterize pulmonary nodules Chest 128 2005 2490 2496